Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036-Reference-Cited by-同舟云学术

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Published:2011-04 Issue:4 Volume:19 Page:556-568
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Chan Wayne W.,Wise Scott C.,Kaufman Michael D.,Ahn Yu Mi,Ensinger Carol L.,Haack Torsten,Hood Molly M.,Jones Jennifer,Lord John W.,Lu Wei Ping,Miller David,Patt William C.,Smith Bryan D.,Petillo Peter A.,Rutkoski Thomas J.,Telikepalli Hanumaiah,Vogeti Lakshminarayana,Yao Tony,Chun Lawrence,Clark Robin,Evangelista Peter,Gavrilescu L. Cristina,Lazarides Katherine,Zaleskas Virginia M.,Stewart Lance J.,Van Etten Richard A.,Flynn Daniel L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference36 articles.

1. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL;Azam;Cell,2003

2. Activation of tyrosine kinases by mutation of the gatekeeper threonine;Azam;Nat. Struct. Mol. Biol.,2008

3. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

4. Specific targeted therapy of chronic myelogenous leukemia with imatinib;Deininger;Pharmacol. Rev.,2003

5. Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia;Donato;Biochem. Pharmacol.,2010

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Potential of Ginkgo biloba Polyphenols in Targeting Biomarkers of Colorectal Cancer: An In-silico Evaluation;Current Drug Discovery Technologies;2024-11

2. In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I;Molecules;2024-09-08

3. Elucidating the phosphoregulatory network of predominant phosphosite in AXL kinase: an integrative bioinformatic approach;Journal of Proteins and Proteomics;2024-06-19

4. Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia;International Journal of Molecular Sciences;2024-03-14

5. Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies;European Journal of Pharmaceutical Sciences;2024-02